Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

FOSINOPRIL SODIUM

10 general benefit · 2 not a benefit

Other products in the same Health Canada class (C09AA) — coverage varies; not interchangeable

  • Benazepril (Lotensin): general benefit, Not a benefit
  • Captopril (Noyada): general benefit, Limited Use 707, 723, Not a benefit
  • Cilazapril (Inhibace): general benefit, Not a benefit
  • Enalapril (Vasotec): general benefit, Not a benefit
  • Lisinopril (Prinivil): general benefit, Not a benefit
  • Perindopril erbumine (Coversyl): general benefit

3 more in the class list below

Apo-Fosinopril · DIN 02266008 · 10mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Fosinopril · DIN 02266008 Manufacturer: Apotex Inc.; listing date 2005-07-14 Daily cost (source): $0.2178 Health Canada: Marketed since 2005-04-27 · brand APO-FOSINOPRIL · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 10 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Fosinopril: Formulary list price $0.2178/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2178 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75144 · Verify on the e-Formulary ↗ (DIN 02266008)

Source record
DIN 02266008: Apo-Fosinopril Raw flags: chronicUseMed=Y, sec3=Y Item: 240800156; group id 328; item number 0731; lccId None; manufacturer id APX Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2178; ministry $0.2178 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02266008 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75144
Interchangeable products
Fosinopril · DIN 02459388 · $0.2178 Jamp-Fosinopril · DIN 02331004 · $0.2178 Monopril · DIN 01907107 · not recorded Ran-Fosinopril · DIN 02294524 · $0.2178 Teva-Fosinopril · DIN 02247802 · $0.2178
Shortage status: resolved shortage (ended 2024-05-02); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02266008
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Fosinopril · DIN 02459388 · 10mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Fosinopril · DIN 02459388 Manufacturer: Sanis Health Inc.; listing date 2020-06-30 Daily cost (source): $0.2178 Health Canada: Marketed since 2017-04-11 · brand FOSINOPRIL · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 10 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Fosinopril: Formulary list price $0.2178/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2178 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94662 · Verify on the e-Formulary ↗ (DIN 02459388)

Source record
DIN 02459388: Fosinopril Raw flags: chronicUseMed=Y, sec3=Y Item: 240800156; group id 328; item number 0731; lccId None; manufacturer id SAI Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2178; ministry $0.2178 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02459388 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94662
Interchangeable products
Apo-Fosinopril · DIN 02266008 · $0.2178 Jamp-Fosinopril · DIN 02331004 · $0.2178 Monopril · DIN 01907107 · not recorded Ran-Fosinopril · DIN 02294524 · $0.2178 Teva-Fosinopril · DIN 02247802 · $0.2178
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02459388
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Fosinopril · DIN 02247802 · 10mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Fosinopril · DIN 02247802 Manufacturer: Teva Canada Limited; listing date 2004-04-06 Daily cost (source): $0.2178 Health Canada: Marketed since 2010-05-01 · brand TEVA-FOSINOPRIL · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 10 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Fosinopril: Formulary list price $0.2178/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2178 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=72096 · Verify on the e-Formulary ↗ (DIN 02247802)

Source record
DIN 02247802: Teva-Fosinopril Raw flags: chronicUseMed=Y, sec3=Y Item: 240800156; group id 328; item number 0731; lccId None; manufacturer id TEV Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2178; ministry $0.2178 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02247802 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=72096
Interchangeable products
Apo-Fosinopril · DIN 02266008 · $0.2178 Fosinopril · DIN 02459388 · $0.2178 Jamp-Fosinopril · DIN 02331004 · $0.2178 Monopril · DIN 01907107 · not recorded Ran-Fosinopril · DIN 02294524 · $0.2178
Shortage status: discontinued (2019-05-01, reported by TEVA CANADA LIMITED); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02247802
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Fosinopril · DIN 02266016 · 20mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Fosinopril · DIN 02266016 Manufacturer: Apotex Inc.; listing date 2005-07-14 Daily cost (source): $0.2619 Health Canada: Marketed since 2005-04-27 · brand APO-FOSINOPRIL · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 20 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Fosinopril: Formulary list price $0.2619/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2619 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75145 · Verify on the e-Formulary ↗ (DIN 02266016)

Source record
DIN 02266016: Apo-Fosinopril Raw flags: chronicUseMed=Y, sec3=Y Item: 240800157; group id 328; item number 0732; lccId None; manufacturer id APX Source form: Tab; strength: 20mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2619; ministry $0.2619 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02266016 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=75145
Interchangeable products
Fosinopril · DIN 02459396 · $0.2619 Jamp-Fosinopril · DIN 02331012 · $0.2619 Monopril · DIN 01907115 · not recorded Ran-Fosinopril · DIN 02294532 · $0.2619 Teva-Fosinopril · DIN 02247803 · $0.2619
Shortage status: resolved shortage (ended 2024-04-25); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02266016
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Fosinopril · DIN 02459396 · 20mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Fosinopril · DIN 02459396 Manufacturer: Sanis Health Inc.; listing date 2020-06-30 Daily cost (source): $0.2619 Health Canada: Marketed since 2017-04-11 · brand FOSINOPRIL · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 20 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Fosinopril: Formulary list price $0.2619/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2619 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94663 · Verify on the e-Formulary ↗ (DIN 02459396)

Source record
DIN 02459396: Fosinopril Raw flags: chronicUseMed=Y, sec3=Y Item: 240800157; group id 328; item number 0732; lccId None; manufacturer id SAI Source form: Tab; strength: 20mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2619; ministry $0.2619 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02459396 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94663
Interchangeable products
Apo-Fosinopril · DIN 02266016 · $0.2619 Jamp-Fosinopril · DIN 02331012 · $0.2619 Monopril · DIN 01907115 · not recorded Ran-Fosinopril · DIN 02294532 · $0.2619 Teva-Fosinopril · DIN 02247803 · $0.2619
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02459396
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Fosinopril · DIN 02247803 · 20mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Fosinopril · DIN 02247803 Manufacturer: Teva Canada Limited; listing date 2004-04-06 Daily cost (source): $0.2619 Health Canada: Marketed since 2010-05-01 · brand TEVA-FOSINOPRIL · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 20 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Fosinopril: Formulary list price $0.2619/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2619 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=72097 · Verify on the e-Formulary ↗ (DIN 02247803)

Source record
DIN 02247803: Teva-Fosinopril Raw flags: chronicUseMed=Y, sec3=Y Item: 240800157; group id 328; item number 0732; lccId None; manufacturer id TEV Source form: Tab; strength: 20mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2619; ministry $0.2619 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02247803 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=72097
Interchangeable products
Apo-Fosinopril · DIN 02266016 · $0.2619 Fosinopril · DIN 02459396 · $0.2619 Jamp-Fosinopril · DIN 02331012 · $0.2619 Monopril · DIN 01907115 · not recorded Ran-Fosinopril · DIN 02294532 · $0.2619
Shortage status: discontinued (2019-05-01, reported by TEVA CANADA LIMITED); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02247803
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp-Fosinopril · DIN 02331004 · 10mg · tablet

General benefitDormant since 2017-08-07 · checked 2026-09-02 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp-Fosinopril · DIN 02331004 Manufacturer: Jamp Pharma Corporation; listing date 2010-04-23 Daily cost (source): $0.2178 Health Canada: Dormant since 2017-08-07 · brand JAMP-FOSINOPRIL · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 10 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp-Fosinopril: Formulary list price $0.2178/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2178 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81674 · Verify on the e-Formulary ↗ (DIN 02331004)

Source record
DIN 02331004: Jamp-Fosinopril Raw flags: chronicUseMed=Y, sec3=Y Item: 240800156; group id 328; item number 0731; lccId None; manufacturer id JPC Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2178; ministry $0.2178 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02331004 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81674
Interchangeable products
Apo-Fosinopril · DIN 02266008 · $0.2178 Fosinopril · DIN 02459388 · $0.2178 Monopril · DIN 01907107 · not recorded Ran-Fosinopril · DIN 02294524 · $0.2178 Teva-Fosinopril · DIN 02247802 · $0.2178
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02331004
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2017-08-07 — choose a marketed DIN from the same-category list.

Jamp-Fosinopril · DIN 02331012 · 20mg · tablet

General benefitDormant since 2017-08-07 · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp-Fosinopril · DIN 02331012 Manufacturer: Jamp Pharma Corporation; listing date 2010-04-23 Daily cost (source): $0.2619 Health Canada: Dormant since 2017-08-07 · brand JAMP-FOSINOPRIL · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 20 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp-Fosinopril: Formulary list price $0.2619/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2619 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81675 · Verify on the e-Formulary ↗ (DIN 02331012)

Source record
DIN 02331012: Jamp-Fosinopril Raw flags: chronicUseMed=Y, sec3=Y Item: 240800157; group id 328; item number 0732; lccId None; manufacturer id JPC Source form: Tab; strength: 20mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2619; ministry $0.2619 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02331012 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81675
Interchangeable products
Apo-Fosinopril · DIN 02266016 · $0.2619 Fosinopril · DIN 02459396 · $0.2619 Monopril · DIN 01907115 · not recorded Ran-Fosinopril · DIN 02294532 · $0.2619 Teva-Fosinopril · DIN 02247803 · $0.2619
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02331012
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2017-08-07 — choose a marketed DIN from the same-category list.

Ran-Fosinopril · DIN 02294524 · 10mg · tablet

General benefit; Health Canada lists this DIN as Cancelled post market since 2025-07-10 — choose a marketed DIN from the same-category list.Discontinued 2025-07-10 · checked 2026-09-02
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-07-10 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-07-10 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Ran-Fosinopril · DIN 02294524 Manufacturer: Ranbaxy Pharmaceuticals Canada Inc.; listing date 2010-03-02 Daily cost (source): $0.2178 Health Canada: Cancelled post market since 2025-07-10 · brand RAN-FOSINOPRIL · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 10 MG · company Ranbaxy pharmaceuticals canada inc. · schedule Prescription
Check this DIN again · Health Canada product record

Ran-Fosinopril: Formulary list price $0.2178/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2178 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77986 · Verify on the e-Formulary ↗ (DIN 02294524)

Source record
DIN 02294524: Ran-Fosinopril Raw flags: chronicUseMed=Y, sec3=Y Item: 240800156; group id 328; item number 0731; lccId None; manufacturer id RAN Source form: Tab; strength: 10mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2178; ministry $0.2178 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02294524 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77986
Interchangeable products
Apo-Fosinopril · DIN 02266008 · $0.2178 Fosinopril · DIN 02459388 · $0.2178 Jamp-Fosinopril · DIN 02331004 · $0.2178 Monopril · DIN 01907107 · not recorded Teva-Fosinopril · DIN 02247802 · $0.2178
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02294524
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2025-07-10 — choose a marketed DIN from the same-category list.

Ran-Fosinopril · DIN 02294532 · 20mg · tablet

General benefit; Health Canada lists this DIN as Cancelled post market since 2025-07-10 — choose a marketed DIN from the same-category list.Discontinued 2025-07-10 · checked 2026-09-02
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-07-10 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-07-10 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Ran-Fosinopril · DIN 02294532 Manufacturer: Ranbaxy Pharmaceuticals Canada Inc.; listing date 2010-03-02 Daily cost (source): $0.2619 Health Canada: Cancelled post market since 2025-07-10 · brand RAN-FOSINOPRIL · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 20 MG · company Ranbaxy pharmaceuticals canada inc. · schedule Prescription
Check this DIN again · Health Canada product record

Ran-Fosinopril: Formulary list price $0.2619/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2619 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77987 · Verify on the e-Formulary ↗ (DIN 02294532)

Source record
DIN 02294532: Ran-Fosinopril Raw flags: chronicUseMed=Y, sec3=Y Item: 240800157; group id 328; item number 0732; lccId None; manufacturer id RAN Source form: Tab; strength: 20mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2619; ministry $0.2619 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02294532 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77987
Interchangeable products
Apo-Fosinopril · DIN 02266016 · $0.2619 Fosinopril · DIN 02459396 · $0.2619 Jamp-Fosinopril · DIN 02331012 · $0.2619 Monopril · DIN 01907115 · not recorded Teva-Fosinopril · DIN 02247803 · $0.2619
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02294532
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2025-07-10 — choose a marketed DIN from the same-category list.

Monopril · DIN 01907107 · 10mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2013-06-17 — choose a marketed DIN from the same-category list.Discontinued 2013-06-17 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2013-06-17 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2013-06-17 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Monopril · DIN 01907107 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01 Daily cost (source): $0.2178 Health Canada: Cancelled post market since 2013-06-17 · brand MONOPRIL TAB 10MG · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 10 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Monopril: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12759 · Verify on the e-Formulary ↗ (DIN 01907107)

Source record
DIN 01907107: Monopril Raw flags: chronicUseMed=Y, notABenefit=Y, sec3=Y Item: 240800156; group id 328; item number 0731; lccId None; manufacturer id BQU Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01907107 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12759
Interchangeable products
Apo-Fosinopril · DIN 02266008 · $0.2178 Fosinopril · DIN 02459388 · $0.2178 Jamp-Fosinopril · DIN 02331004 · $0.2178 Ran-Fosinopril · DIN 02294524 · $0.2178 Teva-Fosinopril · DIN 02247802 · $0.2178
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01907107
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2013-06-17 — choose a marketed DIN from the same-category list.

Monopril · DIN 01907115 · 20mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2013-06-17 — choose a marketed DIN from the same-category list.Discontinued 2013-06-17 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2013-06-17 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2013-06-17 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Monopril · DIN 01907115 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01 Daily cost (source): $0.2619 Health Canada: Cancelled post market since 2013-06-17 · brand MONOPRIL TAB 20MG · ATC C09AA09 FOSINOPRIL · form Tablet · route Oral · ingredients FOSINOPRIL SODIUM 20 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Monopril: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12760 · Verify on the e-Formulary ↗ (DIN 01907115)

Source record
DIN 01907115: Monopril Raw flags: chronicUseMed=Y, notABenefit=Y, sec3=Y Item: 240800157; group id 328; item number 0732; lccId None; manufacturer id BQU Source form: Tab; strength: 20mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01907115 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12760
Interchangeable products
Apo-Fosinopril · DIN 02266016 · $0.2619 Fosinopril · DIN 02459396 · $0.2619 Jamp-Fosinopril · DIN 02331012 · $0.2619 Ran-Fosinopril · DIN 02294532 · $0.2619 Teva-Fosinopril · DIN 02247803 · $0.2619
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01907115
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2013-06-17 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (24:08 Hypotensive Drugs (For Diuretics See 40:28)) and how they are covered

Matched class: 24:08 Hypotensive Drugs (For Diuretics See 40:28)

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL & HYDROCHLOROTHIAZIDE, CILAZAPRIL & HYDROCHLOROTHIAZIDE, LABETALOL HCL, LOSARTAN POTASSIUM, LOSARTAN POTASSIUM & HYDROCHLOROTHIAZIDE, MINOXIDIL, OLMESARTAN MEDOXOMIL, OLMESARTAN MEDOXOMIL & HYDROCHLOROTHIAZIDE, PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE & INDAPAMIDE, PINDOLOL & HYDROCHLOROTHIAZIDE, TELMISARTAN, TELMISARTAN & AMLODIPINE BESYLATE, TELMISARTAN & HYDROCHLOROTHIAZIDE, VALSARTAN & HYDROCHLOROTHIAZIDE Some products covered without a code (check the product listing): ATENOLOL & CHLORTHALIDONE, BENAZEPRIL, CAPTOPRIL, CILAZAPRIL, CLONIDINE HCL, DOXAZOSIN MESYLATE, ENALAPRIL MALEATE, FELODIPINE, HYDRALAZINE HCL, IRBESARTAN, IRBESARTAN & HYDROCHLOROTHIAZIDE, LISINOPRIL, LISINOPRIL & HYDROCHLOROTHIAZIDE, METHYLDOPA, NIFEDIPINE, PINDOLOL, PRAZOSIN HCL, QUINAPRIL, QUINAPRIL & HYDROCHLOROTHIAZIDE, RAMIPRIL, RAMIPRIL & HYDROCHLOROTHIAZIDE, TERAZOSIN HCL, TRANDOLAPRIL, VALSARTAN, VERAPAMIL HCL 24:08 Hypotensive Drugs (For Diuretics See 40:28)

BENAZEPRIL

· 6 products · Listed, not a benefit (3), General benefit (3) · strengths: 5mg, 10mg, 20mg · Tab

CAPTOPRIL

· 14 products · Limited Use, codes 707, 723 (2), Listed, not a benefit (4), General benefit (8) · strengths: 5mg/5mL, 25mg/5mL, 12.5mg, 25mg, 50mg, 100mg · Oral Sol, Tab

CILAZAPRIL

· 8 products · Listed, not a benefit (2), General benefit (6) · strengths: 1mg, 2.5mg, 5mg · Tab

ENALAPRIL MALEATE

· 52 products · Listed, not a benefit (1), General benefit (51) · strengths: 2.5mg, 5mg, 10mg, 20mg · Tab

LISINOPRIL

· 45 products · Listed, not a benefit (1), General benefit (44) · strengths: 5mg, 10mg, 20mg · Tab

PERINDOPRIL ERBUMINE

· 45 products · General benefit · strengths: 2mg, 4mg, 8mg · Tab

QUINAPRIL

· 12 products · Listed, not a benefit (4), General benefit (8) · strengths: 5mg, 10mg, 20mg, 40mg · Tab

RAMIPRIL

· 67 products · General benefit (57), Listed, not a benefit (4), Off-Formulary Interchangeable, not an ODB benefit (6) · strengths: 1.25mg, 2.5mg, 5mg, 10mg, 15mg · Cap

TRANDOLAPRIL

· 26 products · Off-Formulary Interchangeable, not an ODB benefit (5), General benefit (21) · strengths: 0.5mg, 1mg, 2mg, 4mg · Cap

ATENOLOL & CHLORTHALIDONE

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 50 & 25mg, 100 & 25mg · Tab

CANDESARTAN CILEXETIL

· 59 products · General benefit · strengths: 4mg, 8mg, 16mg, 32mg · Tab

CANDESARTAN CILEXETIL & HYDROCHLOROTHIAZIDE

· 21 products · General benefit · strengths: 16mg & 12.5mg, 32mg & 12.5mg, 32mg & 25mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 24:08 and 35 more
Full class listing Related classes: 24:04 Cardiac Drugs, 24:06 Antilipemic Drugs, 24:12 Vasodilating Drugs, 24:32 Renin-Angiotensin Aldosterone Inhibitors Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE TEVA-FOSINOPRIL (fosinopril sodium) is indicated in the treatment of mild to moderate essential hypertension. It may be used alone or in association with thiazide diuretics. In using TEVA-FOSINOPRIL consideration should be given to the risk of angioedema (see WARNINGS). TEVA-FOSINOPRIL should normally be used in those patients in whom treatment with a diuretic or a beta-blocker was found ineffective or has been associated with unacceptable adverse effects. TEVA-FOSINOPRIL can also be tried as an initial agent in those patients in whom use of diuretics and/or beta-blockers is contraindicated or in patients with medical conditions in which these drugs frequently cause serious adverse effects. 5 The safety and efficacy of TEVA-FOSINOPRIL in renovascular hypertension has not been established and therefore, its use in this condition is not recommended. The safety and efficacy of concurrent use of TEVA-FOSINOPRIL with antihypertensive agents other than thiazide diuretics have not been established. TEVA-FOSINOPRIL i… https://pdf.hres.ca/dpd_pm/00074853.PDF PM date: MAR 07, 2024 Source product: TEVA-FOSINOPRIL; DIN 02247802; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Teva-Fosinopril · DIN 02247802 Shortage status: discontinued (2019-05-01, reported by TEVA CANADA LIMITED); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02247802

Check this DIN again

Teva-Fosinopril · DIN 02247803 Shortage status: discontinued (2019-05-01, reported by TEVA CANADA LIMITED); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02247803

Check this DIN again
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)

Other review policies

For Monopril: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026